Hunter Simpson, MD
Pain Medicine · New Orleans, LANPI 1578092870
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,137 of the $2,702 with a category attached, or 79.1%. 17 manufacturers reported payments, led by Abbott at 38.8% of the total. Reporting peaked in 2023 at $1,856 and has fallen 91.4% since, to $159 in 2025. That places this record below the midpoint for pain medicine clinicians in LA, where the typical reported total is $3,650.
Across 100 payments — averaging $27.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- AbbVie$553
- Pfizer$355
- Collegium Pharmaceutical, Inc.$213
- Globus Medical$143
- Idorsia Pharmaceuticals US Inc$114
- plus $275 from 11 others
What the payments were for
- Travel & lodging$56521%
- Food & beverage$2,13779%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,702 in reported general payments places this provider in the 40th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 479 | $48,553 |
| RelistorMethylnaltrexone Bromide | 18 | $39,431 |
| UbrelvyUbrogepant | 20 | $27,943 |
| BelbucaBuprenorphine Hcl | 31 | $25,540 |
| QuliptaAtogepant | 22 | $23,329 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 567 | $15,638 |
| Lidocaine | 117 | $9,348 |
| Xtampza ErOxycodone Myristate | 18 | $7,177 |
| ZtlidoLidocaine | 16 | $5,784 |
| MovantikNaloxegol Oxalate | 13 | $4,859 |
| Buprenorphine | 13 | $4,102 |
| Tramadol Hcl | 136 | $3,331 |
| Gabapentin | 327 | $3,318 |
| Naloxone Hcl | 37 | $2,655 |
| Pregabalin | 149 | $2,189 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $553 | $51,27242 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $30 | $39,43118 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $213 | $32,71649 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $21 | $5,78416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 97 pain medicine providers in Louisiana.
Other pain medicine in New Orleans
- Alan KayeNew Orleans$76K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Yashar EshraghiNew Orleans$22K
- Aaron Hanyu-DeutmeyerNew Orleans$17K
- Trevor JohnsonNew Orleans$11K
- Eric RoysterNew Orleans$10K
- Lesley WalshNew Orleans$10K
- Alvah WickboldtNew Orleans$7K
- Arya BekhradiNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.